Kynam Capital Management, LP Celldex Therapeutics, Inc. Call Options Transaction History
Kynam Capital Management, LP
- $1.28 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$357 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$165 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$147 Million2.17% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.17MShares$140 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $2.07B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...